From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
August 14, 2019
Philadelphia, PA, August 14, 2019 – IntegriChain, a leading life sciences commercial data and analytics company that helps patients start therapy faster and stay on therapy longer, today announced it was recognized in two areas of Gartner’s Hype Cycle for Life Sciences Commercial Operations 2019, which is available on Gartner.com. IntegriChain is included as a sample vendor for both Revenue Management and Life Sciences Commercial Analytics.
“We are excited to increase our presence in the Gartner Hype Cycle for these two critical areas of Life Sciences market access and commercial operations,” said IntegriChain CEO Kevin Leininger. “Following our merger with daVIZta earlier this year, we now deliver a broad solution set of Payer data, analytics and managed services for revenue management to help life sciences manufacturers control revenue leakage, manage contract complexity, and solve the industry’s gross-to-net challenges. These offerings — along with our Distribution solutions for maximizing trade and channel investment and our Patient solutions to improve patient access – combine to deliver a powerful insights platform to help patients start therapy sooner and stay on therapy longer. With such an extensive and growing platform and now more than 165 Life Sciences customers — from Big Pharma to emerging — we’re delighted to be recognized by Gartner.”
About IntegriChain
IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our data-science-driven ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 165 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Atlanta, GA, and Pune, India. For more information, visit www.integrichain.com and our blog, or follow us on Twitter @IntegriChain and LinkedIn.
Contact
Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | jennifer@sagestrat.com
Register Now
Webinars & Resources
See List
